The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...

Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Ask a friend what DNA is and, chances are, they have a general idea. Seventy years after scientists discovered the two-stranded helix, DNA (deoxyribonucleic acid) is widely understood as the keeper of ...

A 46% premium paid for RNA candidates reflects what the pharma giant has sought to do for the last few years: aim at ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic blueprint that cells in our bodies use to make proteins. RNA has been in the ...

Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...

Exsilio Therapeutics has launched with $82 million in series A funding. Exsilio uses lipid nanoparticles and messenger RNA (mRNA) to integrate whole corrective genes into “safe harbors” in the ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...

mRNA transports the most valuable cellular information - the chemical blueprint for the production of proteins - from the nucleus into the cytoplasm. However, as soon as mRNA has delivered its message ...